These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7690370)

  • 21. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
    Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
    Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
    D'Cruz OJ; Haas GG
    Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
    Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
    J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement regulatory proteins on the sperm surface: relevance to sperm motility.
    Jiang H; Pillai S
    Am J Reprod Immunol; 1998 Apr; 39(4):243-8. PubMed ID: 9553648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
    Simpson KL; Holmes CH
    Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation.
    Gordon DL; Sadlon TA; Wesselingh SL; Russell SM; Johnstone RW; Purcell DF
    J Neuroimmunol; 1992 Feb; 36(2-3):199-208. PubMed ID: 1370668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion.
    Jensen TS; Bjørge L; Wollen AL; Ulstein M
    Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.
    Marchbank KJ; Morgan BP; van den Berg CW
    Immunology; 1995 May; 85(1):146-52. PubMed ID: 7543447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
    Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
    Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
    Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
    Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
    Varsano S; Frolkis I; Shapiro H; Ophir D
    Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
    Miwa T; Song WC
    Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
    Miwa T; Okada N; Okada H
    Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.